辅助抗肿瘤免疫增强药物不合理用药调查

Survey of Irrational Use of Anti-tumor Immune Enhancement Drugs

目的:对我院辅助抗肿瘤免疫增强药物合理使用进行调查分析。方法:收集2015年全年我院辅助抗肿瘤免疫增强药物使用数据,结合病史信息,进行处方点评和统计分析。结果:我院共12个品种19个品规辅助抗肿瘤免疫增强药物,占总用药金额的15.87%。共25 481患者使用该类药品,在患者药品费用负担中占比达29.84%。辅助抗肿瘤免疫增强药物存在多种不合理使用现象,不合理用药主要是过度使用和超适应征使用。结论:加强此类药物的处方点评,合理控制使用辅助抗肿瘤免疫增强药物十分必要。

Objective ： To investigate and analyze the rational use of anti-tumor immune enhancement drugs in our hospital. Meth- ods： The annual use data of anti-tumor immune enhancement drugs in our hospital in 2015 were collected, and then statistically ana- lyzed and evaluated combing with the medical history information. Results： There were 12 varieties and 19 specifications of adjuvant anti-tumor immune enhancement drugs in our hospital, which accounted for 15.87% of the total sum. Totally 25 481 patients used ad- juvant anti-tumor immune enhancement drugs, which occupied 29.84% of the total medicine afford. The adjuvant anti-tumor immune enhancement drugs showed lots of irrational use in clinics, and the main irrationity was overuse and off-label use. Conclusion： It is necessary to strengthen prescription evaluation for anti-tumor immune enhancement drugs, which needs controlled and rational use.